VACC Insider Trading

Insider Ownership Percentage: 6.00%
Insider Buying (Last 12 Months): $60,975.00
Insider Selling (Last 12 Months): $0.00

Vaccitech Insider Trading History Chart

This chart shows the insider buying and selling history at Vaccitech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vaccitech Share Price & Price History

Current Price: $2.38
Price Change: Price Increase of +0.05 (2.15%)
As of 03/28/2024 01:00 AM ET

This chart shows the closing price history over time for VACC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Vaccitech Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/26/2023Joseph ScheerenDirectorBuy10,000$2.44$24,400.0023,000View SEC Filing Icon  
5/25/2023Robin WrightDirectorBuy13,750$2.66$36,575.0048,256View SEC Filing Icon  
3/27/2023William EnrightCEOSell15,000$2.42$36,300.00728,454View SEC Filing Icon  
8/25/2022Graham GriffithsInsiderSell10,000$7.39$73,900.00104,209View SEC Filing Icon  
8/24/2022Christopher EllisCOOSell450$4.78$2,151.0075View SEC Filing Icon  
8/18/2022Christopher EllisCOOSell2,175$4.84$10,527.0075View SEC Filing Icon  
8/17/2022Graham GriffithsInsiderSell500$4.76$2,380.00114,209View SEC Filing Icon  
8/12/2022Graham GriffithsInsiderSell5,000$4.50$22,500.00118,329View SEC Filing Icon  
6/28/2022Christopher EllisCOOSell5$6.00$30.0075View SEC Filing Icon  
6/23/2022Graham GriffithsInsiderSell8$5.28$42.24123,229View SEC Filing Icon  
4/1/2022Joseph ScheerenDirectorBuy10,000$5.09$50,900.003,000View SEC Filing Icon  
12/22/2021Robin WrightDirectorBuy10,000$9.97$99,700.00View SEC Filing Icon  
5/4/2021Christopher EllisCOOBuy75$17.00$1,275.0075View SEC Filing Icon  
5/4/2021Graham GriffithsInsiderBuy100$17.00$1,700.00100View SEC Filing Icon  
5/4/2021Karen A. DawesDirectorBuy1,700$17.00$28,900.001,700View SEC Filing Icon  
5/4/2021Sciences Innovation Plc OxfordMajor ShareholderBuy600,000$17.00$10,200,000.004,832,142View SEC Filing Icon  
4/30/2021M&G Investment Management LtdMajor ShareholderBuy125,000$14.40$1,800,000.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Vaccitech (NASDAQ:VACC)

26.13% of Vaccitech stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VACC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Vaccitech Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/31/2024Ipswich Investment Management Co. Inc.23,075$0.12M0.0%-14.8%0.060%Search for SEC Filing on Google Icon
11/8/2023Janney Montgomery Scott LLC15,008$46K0.0%N/A0.039%Search for SEC Filing on Google Icon
8/15/2023Citadel Advisors LLC14,877$31K0.0%N/A0.039%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC34,000$70K0.0%+198.2%0.089%Search for SEC Filing on Google Icon
8/11/2023Baird Financial Group Inc.196,296$0.40M0.0%+9.5%0.512%Search for SEC Filing on Google Icon
5/15/2023Liontrust Investment Partners LLP455,848$1.02M0.0%-24.0%1.189%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC11,400$26K0.0%N/A0.030%Search for SEC Filing on Google Icon
4/24/2023Ipswich Investment Management Co. Inc.27,075$61K0.0%+26.7%0.071%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC40,388$97K0.0%+32.8%0.108%Search for SEC Filing on Google Icon
2/13/2023Baird Financial Group Inc.92,461$0.22M0.0%N/A0.248%Search for SEC Filing on Google Icon
11/16/2022Alphabet Inc.1,513,644$4.84M0.2%N/A4.058%Search for SEC Filing on Google Icon
11/1/2022M&G Investment Management Ltd.5,197,349$15.59M0.1%+377.4%13.964%Search for SEC Filing on Google Icon
10/11/2022Ipswich Investment Management Co. Inc.23,475$75K0.0%-41.3%0.063%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC61,395$0.27M0.0%-10.6%0.165%Search for SEC Filing on Google Icon
7/26/2022Ipswich Investment Management Co. Inc.39,975$0.18M0.1%-23.7%0.107%Search for SEC Filing on Google Icon
2/14/2022Johns Hopkins University107,968$1.20M0.1%N/A0.310%Search for SEC Filing on Google Icon
2/14/2022ETF Managers Group LLC10,087$0.11M0.0%-21.9%0.029%Search for SEC Filing on Google Icon
11/22/2021Liontrust Investment Partners LLP600,000$9.44M0.1%N/A1.720%Search for SEC Filing on Google Icon
11/16/2021Brookfield Asset Management Inc.15,921$0.25M0.0%-36.3%0.046%Search for SEC Filing on Google Icon
11/15/2021Tudor Investment Corp Et Al378,260$5.73M0.0%-10.0%1.102%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP10,251$0.16M0.0%-79.5%0.030%Search for SEC Filing on Google Icon
11/12/2021Ghisallo Capital Management LLC20,625$0.33M0.0%+106.3%0.060%Search for SEC Filing on Google Icon
10/7/2021Ipswich Investment Management Co. Inc.51,475$0.81M0.2%+18.9%0.150%Search for SEC Filing on Google Icon
8/23/2021DC Funds LP642,204$10.78M51.2%N/A1.871%Search for SEC Filing on Google Icon
8/17/2021Brookfield Asset Management Inc.25,000$0.42M0.0%N/A0.073%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC130,137$2.18M0.0%N/A0.379%Search for SEC Filing on Google Icon
8/17/2021Caas Capital Management LP50,000$0.84M0.0%N/A0.146%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC25,000$0.42M0.0%N/A0.073%Search for SEC Filing on Google Icon
8/16/2021M&G Investment Management Ltd.1,088,597$18.51M0.0%N/A3.171%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC11,562$0.19M0.0%N/A0.034%Search for SEC Filing on Google Icon
8/16/2021Tudor Investment Corp Et Al420,319$6.02M0.1%N/A1.224%Search for SEC Filing on Google Icon
8/12/2021Monashee Investment Management LLC132,184$2.22M0.3%N/A0.385%Search for SEC Filing on Google Icon
8/11/2021Arena Capital Advisors LLC CA30,698$0.52M0.0%N/A0.089%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Vaccitech logo
Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B infection; VTP-200 that is in Phase 1/2a clinical trial for the treatment of human papilloma virus infection; VTP-850, which is in Phase 1/2 clinical trial for the treatment of prostate cancer; and VTP-600 that is in Phase 1/2a clinical trial for the treatment of non-small cell lung cancer. Its prophylactic programs include VTP-400, which is in preclinical stage for the prevention of herpes zoster or shingles; VTP-500 that has completed Phase 1 clinical trial for the prevention of Middle East respiratory syndrome; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious and autoimmunity diseases, and cancers. The company's therapeutic programs include VTP-300, which is in Phase 2a clinical trial for the treatment of chronic hepatitis B infection; VTP-200 that is in Phase 1b/2 clinical trial for the treatment of human papilloma virus infection; VTP-850, which is in Phase 1/2 clinical trial for the treatment of prostate cancer; and VTP-600 that is in Phase 1/2a clinical trial for the treatment of non-small cell lung cancer. Its prophylactic programs include VTP-400, which is in preclinical stage for the prevention of herpes zoster or shingles; VTP-500 that has completed Phase 1 clinical trial for the prevention of Middle East respiratory syndrome; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc in March 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom.Vaccitech Rx Limited and changed its name to Vaccitech plc in March 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom.
Read More on Vaccitech

Today's Range

Now: $2.38
Low: $2.31
High: $2.47

50 Day Range

MA: $2.73
Low: $2.33
High: $5.00

52 Week Range

Now: $2.38
Low: $1.64
High: $5.10

Volume

32,846 shs

Average Volume

244,643 shs

Market Capitalization

$91.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Vaccitech?

Vaccitech's top insider shareholders include:
  1. William Enright (CEO)
  2. Graham Griffiths (Insider)
  3. Robin Wright (Director)
  4. Joseph Scheeren (Director)
  5. Christopher Ellis (COO)
Learn More about top insider investors at Vaccitech.

Who are the major institutional investors of Vaccitech?

Vaccitech's top institutional investors include:
  1. Ipswich Investment Management Co. Inc. — 0.06%
Learn More about top institutional investors of Vaccitech stock.

Which institutional investors are selling Vaccitech stock?

In the last quarter, VACC stock was sold by these institutional investors:
  1. Ipswich Investment Management Co. Inc.